Evotec acquires Sanofi infectious disease unit

19-06-2018

Evotec acquires Sanofi infectious disease unit

designer491 / iStockphoto.com

Germany-based drug discovery company Evotec has signed a deal to acquire most of Sanofi’s infectious disease unit.


Evotec, Sanofi, infectious diseases, research and development, mergers and acquisitions, M&A, antivirals

LSIPR